Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Altimmune (ALT) Depreciation & Amortization - Total: 2011-2016

Historic Depreciation & Amortization - Total for Altimmune (ALT) over the last 6 years, with Dec 2016 value amounting to $143,437.

  • Altimmune's Depreciation & Amortization - Total fell 12.45% to $33,007 in Q1 2017 from the same period last year, while for Mar 2017 it was $138,743, marking a year-over-year decrease of 2.43%. This contributed to the annual value of $143,437 for FY2016, which is 1.29% up from last year.
  • According to the latest figures from FY2016, Altimmune's Depreciation & Amortization - Total is $143,437, which was up 1.29% from $141,604 recorded in FY2015.
  • Over the past 5 years, Altimmune's Depreciation & Amortization - Total peaked at $303,916 during FY2012, and registered a low of $141,604 during FY2015.
  • Moreover, its 3-year median value for Depreciation & Amortization - Total was $143,437 (2016), whereas its average is $145,000.
  • As far as peak fluctuations go, Altimmune's Depreciation & Amortization - Total tumbled by 39.95% in 2013, and later rose by 1.29% in 2016.
  • Altimmune's Depreciation & Amortization - Total (Yearly) stood at $303,916 in 2012, then crashed by 39.95% to $182,487 in 2013, then dropped by 17.83% to $149,958 in 2014, then decreased by 5.57% to $141,604 in 2015, then rose by 1.29% to $143,437 in 2016.